Figure Technology Solutions Announces Community Approved Update to Provenance Blockchain Foundation Structure

(NASDAQ:FIGR), NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Figure Technology Solutions (“Figure”, Nasdaq: FIGR), the leading blockchain-native capital marketplace for the origination, funding, sale and trading of on-chain private credit and tokenized real-world assets (RWAs), today announced that it will be taking on the responsibility of executing the community directives for the Provenance Blockchain […]

Jessup University Establishes New Presidential Advisory Board

SACRAMENTO, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Jessup University, in collaboration with the Board of Trustees, today announced the formation of a new Presidential Advisory Board. The Presidential Advisory Board brings together a distinguished group of senior leaders from across Christian higher education and industry to partner with Interim President Dr. Parnell Lovelace and

Computer History Museum Launches Digital Portal to Its Vast Collection

Mountain View, California, Jan. 21, 2026 (GLOBE NEWSWIRE) — The Computer History Museum (CHM), a leader in decoding technology–its computing past, digital present, and future impact on humanity–announced the launch of OpenCHM, a new digital portal providing global access to its unparalleled collection. “OpenCHM is designed to inspire discovery, spark curiosity, and make the stories

Bronstein, Gewirtz & Grossman LLC Urges Smartsheet Inc. Investors to Act: Class Action Filed Alleging Investor Harm

(NYSE:SMAR), NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed on behalf of all former stockholders of Smartsheet Inc. (NYSE: SMAR) in connection with the January 2025 sale (the “Merger” or “Buyout”) of Smartsheet to affiliates

Bronstein, Gewirtz & Grossman LLC Urges Bath & Body Works, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

(NYSE:BBWI), NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Bath & Body Works, Inc. (NYSE: BBWI) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the

Bronstein, Gewirtz & Grossman LLC Urges Fermi Inc. Investors to Act: Class Action Filed Alleging Investor Harm

(NASDAQ:FRMI), NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Fermi Inc. (NASDAQ: FRMI) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws

Bronstein, Gewirtz & Grossman LLC Urges Ardent Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

(NYSE:ARDT), NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Ardent Health, Inc. (NYSE: ARDT) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities

Bronstein, Gewirtz & Grossman LLC Urges F5, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

(NASDAQ:FFIV), NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against F5, Inc. (NASDAQ: FFIV) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws

OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101)

(Paris:OSE), OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) Nantes, France, January 21, 2026 – 6pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today acknowledges the announcement by its partner Veloxis Pharmaceuticals, Inc. that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to pegrizeprument (VEL-101) for

TMC Welcomes NOAA Rule Modernizing Deep-Seabed Mining Permits for U.S. Companies in the High Seas

TMC Welcomes NOAA Rule Modernizing Deep-Seabed Mining Permits for U.S. Companies in the High Seas GlobeNewswire January 21, 2026 Final rule establishes a consolidated application and review process for exploration licenses and commercial recovery permits under the Deep Seabed Hard Mineral Resources Act (DSHMRA) Updated regulations reflect advances in environmental science, seafloor mapping, and offshore

Scroll to Top